News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

The ICR logo on the Brookes Lawley Building
Latest ICR update concerning coronavirus - 17 March

17/03/20

The Institute of Cancer Research, London, is doing everything it can to safeguard its staff and students in response to the coronavirus pandemic while attempting to minimise the inevitable disruption to its life-saving research.
The ICR logo on the Brookes Lawley Building
ICR updates on its response to coronavirus - 14 March

14/03/20

The Institute of Cancer Research, London, is continuing to do its life-saving cancer research in line with Government guidance on coronavirus while making extensive preparations for disruption ahead.
ICR Logo
Weight gain linked to lower risk of breast cancer before the menopause

13/03/20

Gaining weight from early adulthood is linked to a lower risk of breast cancer before the menopause, a major global study of more than 600,000 women has found.
ICR Logo
Two-pronged attack on DNA repair could kill drug-resistant cancers

12/03/20

Launching a two-pronged attack on cancer’s ability to safeguard its DNA could offer an effective new way of treating the disease, a new study reports.
The ICR logo on the Brookes Lawley Building
ICR recognised in Budget as world-leading research centre

11/03/20

The ICR is set to receive extra Government funding after being recognised in the Budget as a world-leading specialist institution.
Immunofluorescent image of autophagosomes in multiple myeloma cells 547x410px
Genetic test could pick out 'ultra high risk' bone marrow cancer patients

11/03/20

A new genetic test could help doctors pick out patients with the bone marrow cancer multiple myeloma who are at ‘ultra high risk’ of their cancer progressing aggressively early on.
Sally Steadman-South and family
Time for family, friends and travel most valued by patients living with cancer

09/03/20

Spending time with family is what cancer patients would most value if new treatments allowed them to live for longer, a new YouGov poll reveals.
International Women's Day 2020 collage
Celebrating five women leading the way at the ICR on International Women's Day 2020

08/03/20

On International Women’s Day 2020, we speak to five women leading the way at the ICR on their journeys in science, their tips for others considering a career in research and the importance of diversity in research.
Urothelial_carcinoma_of_the_ureter 547x410
Chemotherapy after surgery halves risk of rare kidney cancer coming back

05/03/20

Chemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in the disease worldwide has found.
Connective tissue adipose 547x410px
Obesity and tumours: What’s cancer eating for lunch?

04/03/20

Obesity is one of the leading factors contributing to cancer development worldwide. In this feature, Joanne Duffy speaks to Dr Barrie Peck about how fat affects cancer on a molecular level, the relationship between obesity and cancer, and why it's all more complicated than it seems.
Adenocarcinoma
Squaring up to silent tumours: the research burden of pancreatic cancer

29/02/20

This rare disease day, Joanne Duffy looks at some of the cutting-edge research taking place at the ICR.
ICR Logo
World’s largest sarcoma research database aims to revolutionise sarcoma treatment after multi-million pound investment

28/02/20

Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, working alongside collaborators from around the globe, are set to begin work on the world’s largest digital hub of sarcoma clinical and research data after receiving a £2.5m grant.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.